GLP-1 receptor agonists are increasingly used to manage type 2 diabetes and support weight management in the UK
"Insulin-like growth factor-I and wound healing, a potential answer to non-healing wounds: A systematic review of the literature and future perspectives." International Journal of Lower Extremity Wounds
Timing, Safety, and Optimization Explained Discover the best time to take IGF-1 LR3, why fasted and post-workout windows matter, and how to optimize results safely
An Affront to Health Freedom: The FDA Recategorizes 17 Therapeutic Peptides
Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial
The most commonly reported side effects of GLP-1 therapy include nausea, vomiting, constipation, diarrhea, bloating, burping, and dizziness